An artificial intelligence accelerated virtual screening platform for drug discovery
Guangfeng Zhou, Domnița-Valeria Rusnac, Hahnbeom Park, Daniele Canzani, Hai Minh Nguyen, Lance J. Stewart, Matthew F. Bush, Phuong T. Nguyen, Heike Wulff, Vladimir M. Yarov-Yarovoy, Ning Zheng, Frank DiMaio
The paper develops RosettaVS, an AI-accelerated virtual screening platform that identifies drug candidates with high binding affinity across two targets, achieving a 14% and 44% hit rate in under seven days.
Nature Communications · Sep 5, 2024Peer-reviewedBiochemistry